BIBLIOGRAPHIC RECORD
What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Aaron S. Kemp; Nina R. Schooler; Amir H Kalali; Larry D Alphs; Ruban Anand; George Anis Awad; Michael Davidson; Sanjay Dubé; Larry Ereshefsky; Georges M. Gharabawi; Andrew C. Leon; Jean‐Pierre Lépine; Steven G. Potkin; An Vermeulen
- Source of metadata
- OpenAlex
- Year recorded
- 2008
Public identifiers and source
Open the source recordReference
Aaron S. Kemp; Nina R. Schooler; Amir H Kalali; Larry D Alphs; Ruban Anand; George Anis Awad; Michael Davidson; Sanjay Dubé; Larry Ereshefsky; Georges M. Gharabawi; Andrew C. Leon; Jean‐Pierre Lépine; Steven G. Potkin; An Vermeulen. (2008). What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It? https://openalex.org/W2167635958
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-cc805353bbea6765796061e8b35b9e55/